Olema Pharmaceuticals OLMA
NASDAQ OLMA
$8.27 -0.37 (-4.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Olema Pharmaceuticals (OLMA) Cash from Financing Activities (2020 - 2026)

Updated

Olema Pharmaceuticals' Cash from Financing Activities was $1.11 million in Q2 2026, compared with -$2.52 million a year earlier and down 97.6% from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Cash from Financing Activities (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Olema Pharmaceuticals' Cash from Financing Activities was $260.4 million through Jun 30, 2026, up 7.6% year-over-year; for FY2025, it came in at $211.3 million, down 21.4% from FY2024.

  • Cash from Financing Activities shows a five-year compound annual growth rate of -10.0% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $268.82 million in FY2024 (+101.5%), $133.42 million in FY2023, $476,000 in FY2022 (-65.8%) and $1.39 million in FY2021 (-99.6%).
  • Quarterly Cash from Financing Activities has moved between -$2.52 million (Q2 2025) and $244.3 million (Q4 2024) over five years.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q2 2024 (growth of 663.8%); the worst was Q3 2021 (a decline of 99.9%).
  • Per Business Quant data, OLMA's Cash from Financing Activities in the three quarters before Q2 2026 was $45.7 million (Q1 2026), $213.55 million (Q4 2025) and $41,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Olema Pharmaceuticals 755.59 Mn 755.59 Mn - 1.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.11 Mn
Mar 31, 2026 45.70 Mn
Dec 31, 2025 213.55 Mn
Sep 30, 2025 41,000.00
Jun 30, 2025 -2.52 Mn
Mar 31, 2025 222,000.00
Dec 31, 2024 244.30 Mn
Sep 30, 2024 92,000.00
Jun 30, 2024 15.61 Mn
Mar 31, 2024 8.82 Mn
Dec 31, 2023 523,000.00
Sep 30, 2023 130.63 Mn
Jun 30, 2023 2.04 Mn
Mar 31, 2023 220,000.00
Dec 31, 2022 273,000.00
Sep 30, 2022 106,000.00
Jun 30, 2022 64,000.00
Mar 31, 2022 33,000.00
Dec 31, 2021 818,000.00
Sep 30, 2021 57,000.00
API Access

Olema Pharmaceuticals Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OLMA&period=max&api_key=YOUR_API_KEY